USPTO Biotech/Chemical Partnership (BCP) Meetings
In This Section
Biotechnology, Chemical, and Pharmaceutical (BCP) Customer Partnership Meeting - September 7, 2023
Dec 4, 2023, 12:07 PM
by
AIPLA Admin
BCP meetings are part of a long-standing partnership between the USPTO and its valued stakeholders that works to improve the quality of the agency’s products and services. The meeting’s discussion topics include: Summary of Amgen v. Sanofi; 35 U.S.C. 112(a); Reexamination; Best practices to help growth stage companies build their IP portfolio; Patent Center and DOCX; Common sequence compliance errors.
BCP meetings are part of a long-standing partnership between the USPTO and its valued stakeholders that works to improve the quality of the agency’s products and services. The meeting’s discussion topics include: